[1] Assimes TL, Roberts R. Genetics: implications for prevention and management of coronary artery disease[J]. J Am Coll Cardiol, 2016, 68(25): 2797-2818. [2] Meraj PM, Jauhar R, Singh A. Bare metal stents versus drug eluting stents: where do we stand in 2015[J]? Curr Treat Options Cardiovasc Med, 2015, 17(8): 393. [3] Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial[J]. JAMA, 2005, 294(10): 1215-1223. [4] 尹扬光, 黄 岚, 赵晓辉, 等. 非显微外科手术建立小鼠颈动脉损伤模型[J]. 中国应用生理学杂志, 2008, 24(1): 34-35. [5] Plouffe SW, Hong AW, Guan KL. Disease implications of the Hippo/YAP pathway[J]. Trends Mol Med, 2015, 21(4): 212-222. [6] Stone GW, Midei M, Newman W, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease[J]. JAMA, 2008, 299(16): 1903-1913. [7] Indolfi C, De Rosa S, Colombo A. Bioresorbable vascular scaffolds-basic concepts and clinical outcome[J]. Nat Rev Cardiol, 2016, 13(12): 719-729. [8] Li P, Zhu N, Yi B, et al. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation[J]. Circ Res, 2013, 113(10): 1117-1127. [9] Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development anddisease[J]. Annu Rev Physiol, 2012, 74(1): 13-40. [10]Xie C, Guo Y, Zhu T, et al. Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin[J]. J Biol Chem, 2012, 287(18): 14598-14605. [11]周昌钻, 潘孙雷, 林 辉, 等. 瑞舒伐他汀对同型半胱氨酸诱导的小鼠血管平滑肌细胞去分化和内质网应激的影响及其机制研究[J]. 中国应用生理学杂志, 2018, 34(1): 43-48. [12]朱 宁, 赵旭勇, 向贻佳, 等. 大鼠肺细小动脉平滑肌细胞培养新方法的建立及血小板衍生因子对其增殖迁移的影响[J]. 中国应用生理学杂志, 2016, 32(4): 343-346. [13]Davis-Dusenbery BN, Wu C, Hata A. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation[J]. Arterioscler Thromb Vasc Biol, 2011, 31(11): 2370-2377. [14]Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer[J]. Cell, 2015, 163(4): 811-828. [15]Ono H, Ichiki T, Ohtsubo H, et al. Critical role of Mst1 in vascular remodeling after injury[J]. Arterioscler Thromb Vasc Biol, 2005, 25(9): 1871-1876. [16]Kimura TE, Duggirala A, Smith MC, et al. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP[J]. J Mol Cell Cardiol, 2016, 90: 1-10. [17]Zhao B, Ye X, Yu J, et al. TEAD mediates YAP-dependent gene induction and growthcontrol[J]. Genes Dev, 2008, 22(14): 1962-1971. |